BERLIN (Reuters) - Germany will restrict the use of AstraZeneca's COVID-19 vaccine to people aged 60 and over and high-priority groups, Chancellor Angela Merkel said on Tuesday.
The move, agreed with the 16 federal states, follows the recommendation of the independent vaccine committee and comes in response to new reports of a rare brain blood disorder and could turn out as a severe setback to the country's vaccination campaign. [L8N2LS2ZG]
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!